Dec 04, 2021 04:39 PM (GMT+8) · EqualOcean
Recently, the "anti-cancer drug" of 1.2 million yuan for one needle has aroused heated debate. Why is the drug not included in medical insurance? Zheng Jie, director of Beijing Medical Insurance Center, responded that this drug may have good curative effect, but because the price far exceeded the fund capacity and the burden level of the people, it was not economical, failed to pass the review, and finally failed to obtain the qualification for negotiation.